✦ LIBER ✦

Insulin resistance and metabolic syndrome in patients with nonfunctioning adrenal incidentalomas: a cause-effect relationship?

✍ Scribed by Melpomeni Peppa; Eleni Boutati; Chrysi Koliaki; Nasos Papaefstathiou; Efstathios Garoflos; Theofanis Economopoulos; Dimitrios Hadjidakis; Sotirios A. Raptis

Book ID: 113799051
Publisher: Elsevier Science
Year: 2010
Tongue: English
Weight: 160 KB
Volume: 59
Category: Article
ISSN: 1532-8600
DOI: 10.1016/j.metabol.2010.01.007

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

The size of adrenal incidentalomas corre

The size of adrenal incidentalomas correlates with insulin resistance. Is there a cause-effect relationship?

✍ Giovanna Muscogiuri; Gian Pio Sorice; Annamaria Prioletta; Teresa Mezza; Clelia 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 77 KB

P259 Relationship between insulin resist

P259 Relationship between insulin resistance and some coagulation and fibrinolytic parameters in subjects with metabolic syndrome

✍ A. Ragab; N. Abou Samra; A. Higazy; O. Saleh 📂 Article 📅 2007 🏛 Elsevier Science 🌐 English ⚖ 46 KB

274: Gender-specific relationship betwee

274: Gender-specific relationship between circulating leptin and insulin resistance parameters in type 2 diabetic patients with metabolic syndrome

📂 Article 📅 2008 🏛 Elsevier 🌐 English ⚖ 83 KB

Effects of a statin group drug, pravasta

Effects of a statin group drug, pravastatin, on the insulin resistance in patients with metabolic syndrome

✍ Feyzullah Güçlü; Bilgin Özmen; Zeliha Hekimsoy; Cengiz Kirmaz 📂 Article 📅 2004 🏛 Elsevier Science 🌐 English ⚖ 151 KB

Adiponectin, insulin resistance and clin

Adiponectin, insulin resistance and clinical expression of the metabolic syndrome in patients with Type 2 diabetes

✍ Mojiminiyi, O A; Abdella, N A; Al Arouj, M; Ben Nakhi, A 📂 Article 📅 2006 🏛 Nature Publishing Group 🌐 English ⚖ 136 KB

Effect of Metabolic Syndrome Factors and

Effect of Metabolic Syndrome Factors and Insulin Resistance on Ezetimibe/Simvastatin and Atorvastatin Treatment Efficacy in Patients with Metabolic Syndrome and Moderately High/High CHD Risk

✍ Jeffrey B. Rosen; Christie M. Ballantyne; Scott M. Grundy; Willa A. Hsueh; Hans- 📂 Article 📅 2009 🏛 Elsevier 🌐 English ⚖ 264 KB